15 results on '"Jordan M Neil"'
Search Results
2. Smartphone-Based Survey and Message Compliance in Adults Initially Unready to Quit Smoking: Secondary Analysis of a Randomized Controlled Trial
- Author
-
Clayton Ulm, Sixia Chen, Brianna Fleshman, Lizbeth Benson, Darla E Kendzor, Summer Frank-Pearce, Jordan M Neil, Damon Vidrine, and Michael S Businelle
- Subjects
Medicine - Abstract
BackgroundEfficacy of smartphone-based interventions depends on intervention content quality and level of exposure to that content. Smartphone-based survey completion rates tend to decline over time; however, few studies have identified variables that predict this decline over longer-term interventions (eg, 26 weeks). ObjectiveThis study aims to identify predictors of survey completion and message viewing over time within a 26-week smoking cessation trial. MethodsThis study examined data from a 3-group pilot randomized controlled trial of adults who smoke (N=152) and were not ready to quit smoking within the next 30 days. For 182 days, two intervention groups received smartphone-based morning and evening messages based on current readiness to quit smoking. The control group received 2 daily messages unrelated to smoking. All participants were prompted to complete 26 weekly smartphone-based surveys that assessed smoking behavior, quit attempts, and readiness to quit. Compliance was operationalized as percentages of weekly surveys completed and daily messages viewed. Linear regression and mixed-effects models were used to identify predictors (eg, intervention group, age, and sex) of weekly survey completion and daily message viewing and decline in compliance over time. ResultsThe sample (mean age 50, SD 12.5, range 19-75 years; mean years of education 13.3, SD 1.6, range 10-20 years) was 67.8% (n=103) female, 74.3% (n=113) White, 77% (n=117) urban, and 52.6% (n=80) unemployed, and 61.2% (n=93) had mental health diagnoses. On average, participants completed 18.3 (71.8%) out of 25.5 prompted weekly surveys and viewed 207.3 (60.6%) out of 345.1 presented messages (31,503/52,460 total). Age was positively associated with overall weekly survey completion (P=.003) and daily message viewing (P=.02). Mixed-effects models indicated a decline in survey completion from 77% (114/148) in the first week of the intervention to 56% (84/150) in the last week of the intervention (P
- Published
- 2024
- Full Text
- View/download PDF
3. A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial
- Author
-
Jordan M Neil, Christian Senecal, Lauren Ballini, Yuchiao Chang, Brett Goshe, Efren Flores, Jamie S Ostroff, and Elyse R Park
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
BackgroundA cancer diagnosis can catalyze motivation to quit smoking. Tobacco treatment trials offer cessation resources but have low accrual rates. Digital outreach may improve accrual, but knowledge of how best to recruit smokers with recent diagnoses is limited. ObjectiveThis study aims to identify the message frames that were most effective in promoting intent to talk to a physician about participating in a tobacco treatment trial for smokers recently diagnosed with cancer. MethodsFrom February to April 2019, current smokers diagnosed within the past 24 months were recruited from a national web-based panel for a multimethod pilot randomized trial (N=99). Participants were randomized to a 2×3 plus control factorial design that tested 3 unique message frames: proximal versus distal threats of smoking, costs of continued smoking versus benefits of quitting, and gains of participating versus losses of not participating in a tobacco treatment trial. The primary outcome was intent to talk to a physician about participating in a tobacco treatment trial. In phase 1, the main effect within each message factor level was examined using ANOVA and compared with the control condition. Other message evaluation and effectiveness measures were collected and explored in a multivariable model predicting intent to talk to a physician. In phase 2, open-text evaluations of the messages were analyzed using natural language processing software (Leximancer) to generate a thematic concept map and Linguistic Inquiry Word Count to identify and compare the prevalence of linguistic markers among message factors. ResultsOf the 99 participants, 76 (77%) completed the intervention. Participants who received the cost of continued smoking frame were significantly more likely to intend to talk to their physician about participating in a tobacco treatment trial than those who received the benefits of the quitting frame (mean costs 5.13, SD 1.70 vs mean benefits 4.23, SD 1.86; P=.04). Participants who received the proximal risks of continued smoking frame were significantly more likely to seek more information about participating (mean distal 4.83, SD 1.61 vs mean proximal 5.55, SD 1.15; P=.04), and those who received the losses of not participating frame reported significantly improved perceptions of smoking cessation research (mean gain 3.98, SD 0.83 vs mean loss 4.38, SD 0.78; P=.01). Male participants (P=.006) and those with greater message relevancy (P=.001) were significantly more likely to intend to talk to their physician. Participants’ perceptions of their smoking habits, as well as their motivation to quit smoking, were prevalent themes in the open-text data. Differences in the percentages of affective words across message frames were identified. ConclusionsMultimethod approaches are needed to develop evidence-based recruitment messages for patients recently diagnosed with cancer. Future tobacco treatment trials should evaluate the effectiveness of different message frames on smoker enrollment rates. Trial RegistrationClinicaltrials.gov NCT05471284; https://clinicaltrials.gov/ct2/show/NCT05471284
- Published
- 2022
- Full Text
- View/download PDF
4. Development of a Credible Virtual Clinician Promoting Colorectal Cancer Screening via Telehealth Apps for and by Black Men: Qualitative Study
- Author
-
Danyell Wilson-Howard, Melissa J Vilaro, Jordan M Neil, Eric J Cooks, Lauren N Griffin, Taylor T Ashley, Fatemeh Tavassoli, Mohan S Zalake, Benjamin C Lok, Folakemi T Odedina, Francois Modave, Peter J Carek, Thomas J George, and Janice L Krieger
- Subjects
Medicine - Abstract
BackgroundTraditionally, promotion of colorectal cancer (CRC) screening among Black men was delivered by community health workers, patient navigators, and decision aids (printed text or video media) at clinics and in the community setting. A novel approach to increase CRC screening of Black men includes developing and utilizing a patient-centered, tailored message delivered via virtual human technology in the privacy of one’s home. ObjectiveThe objective of this study was to incorporate the perceptions of Black men in the development of a virtual clinician (VC) designed to deliver precision messages promoting the fecal immunochemical test (FIT) kit for CRC screening among Black men in a future clinical trial. MethodsFocus groups of Black men were recruited to understand their perceptions of a Black male VC. Specifically, these men identified source characteristics that would enhance the credibility of the VC. The modality, agency, interactivity, and navigability (MAIN) model, which examines how interface features affect the user’s psychology through four affordances (modality, agency, interactivity, and navigability), was used to assess the presumed credibility of the VC and likability of the app from the focus group transcripts. Each affordance triggers heuristic cues that stimulate a positive or a negative perception of trustworthiness, believability, and understandability, thereby increasing source credibility. ResultsIn total, 25 Black men were recruited from the community and contributed to the development of 3 iterations of a Black male VC over an 18-month time span. Feedback from the men enhanced the visual appearance of the VC, including its movement, clothing, facial expressions, and environmental surroundings. Heuristics, including social presence, novelty, and authority, were all recognized by the final version of the VC, and creditably was established. The VC was named Agent Leveraging Empathy for eXams (ALEX) and referred to as “brother-doctor,” and participants stated “wanting to interact with ALEX over their regular doctor.” ConclusionsInvolving Black men in the development of a digital health care intervention is critical. This population is burdened by cancer health disparities, and incorporating their perceptions in telehealth interventions will create awareness of the need to develop targeted messages for Black men.
- Published
- 2021
- Full Text
- View/download PDF
5. Towards AI-Driven Healthcare: Systematic Optimization, Linguistic Analysis, and Clinicians' Evaluation of Large Language Models for Smoking Cessation Interventions.
- Author
-
Paul Calle, Ruosi Shao, Yunlong Liu, Emily T. Hébert, Darla E. Kendzor, Jordan M. Neil, Michael S. Businelle, and Chongle Pan
- Published
- 2024
- Full Text
- View/download PDF
6. Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]
- Author
-
Brett M. Goshe, Autumn W. Rasmussen, Lynne I. Wagner, JoRean D. Sicks, Ilana F. Gareen, Ruth C. Carlos, Benjamin A. Herman, Angela Wangari Walter, Susan Regan, Douglas E. Levy, Irene Mahon, Alona Muzikansky, Jordan M. Neil, Michelle Lui, Deepika Dilip, Laura Malloy, Irina Gonzalez, Lucy Finkelstein-Fox, Caitlin McCann, Elissa Perez, Jamie S. Ostroff, and Elyse R. Park
- Subjects
Smoking Cessation ,Tobacco Treatment ,Implementing Tobacco Treatment ,Cancer Care ,Randomized Controlled Trial ,Motivational Interviewing ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Persistent smoking among patients diagnosed with cancer is associated with adverse clinical outcomes, yet an evidence-based tobacco use intervention has not been well-integrated into cancer care in community oncology settings. This paper describes the protocol of a nation-wide clinical trial conducted by the ECOG-ACRIN National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base to assess the effectiveness of a virtual tobacco treatment intervention and the process of implementing tobacco treatment in NCORP community oncology settings. Methods/design This two-arm, multisite (n: 49 NCORP sites) hybrid type 1 effectiveness-implementation randomized controlled trial compares the effectiveness of a Virtual Intervention Treatment (VIT) versus an Enhanced Usual Control (EUC) among English and Spanish speaking patients recently diagnosed with cancer, reporting current smoking and receiving care at a participating NCORP Community or Minority/Underserved Site. The VIT includes up to 11 virtual counseling sessions with a tobacco treatment specialist and up to 12 weeks of nicotine replacement therapy (NRT). The EUC arm receives a referral to the NCI Quitline. The primary study outcome is biochemically confirmed 7-day point prevalence smoking abstinence. Moderators of treatment effect will be assessed. The study evaluates implementation processes from participating NCORP site staff via survey, administrative, and focus group data, including reach, acceptability, appropriateness, fidelity, feasibility, adoption, cost and sustainability outcomes. Discussion This trial will generate findings about the effectiveness of an evidence-based virtual tobacco treatment intervention targeting patients diagnosed with cancer and illuminate barriers and facilitators that influence implementing tobacco treatment into community oncology settings nationally. In the era of COVID-19, virtual care solutions are vital for maximizing access and utilization of tobacco treatment delivery. Trial registration ClinicalTrials.gov (NCT03808818) on January 18th, 2019; Last update posted: May 21st, 2020.
- Published
- 2022
- Full Text
- View/download PDF
7. Quit Stage and Intervention Type Differences in the Momentary Within-Person Association Between Negative Affect and Smoking Urges.
- Author
-
Lizbeth Benson, Chaelin K. Ra, Emily T. Hébert, Darla E. Kendzor, Jason A. Oliver, Summer G. Frank-Pearce, Jordan M. Neil, and Michael S. Businelle
- Published
- 2022
- Full Text
- View/download PDF
8. Relations between distress tolerance and psychosocial variables in adults experiencing homelessness
- Author
-
Jillian Robison, Jordan M. Neil, Michael B. Cannell, Jennifer M. Reingle Gonzalez, Michael J. Zvolensky, Chaelin K. Ra, Lorra Garey, Ashley Cole, Krista Kezbers, Audrey Montgomery, and Michael S. Businelle
- Subjects
Social Sciences (miscellaneous) - Published
- 2023
9. Patient-Reported Receipt of Oncology Clinician-Delivered Brief Tobacco Treatment (5As) Six Months following Cancer Diagnosis
- Author
-
Sarah N. Price, Jordan M. Neil, Melissa Flores, Colin Ponzani, Alona Muzikansky, Lauren Ballini, Jamie S. Ostroff, and Elyse R. Park
- Subjects
Cancer Research ,Oncology ,General Medicine - Abstract
Introduction: Smoking after a cancer diagnosis represents a modifiable health risk. It is recommended that oncology clinicians address tobacco use among their patients using the 5As brief model: Asking about use, Advising users to quit, Assessing willingness to quit, Assisting in quit attempts (counseling and medication), and Arranging follow-up. However, cross-sectional studies have found limited adoption of 5As (especially Assist and Arrange) in oncology settings. Further investigation is needed to understand changes in, and factors associated with, 5As delivery over time. Methods: Patients recently diagnosed with cancer and reporting current smoking (N = 303) enrolled in a smoking cessation clinical trial and completed three longitudinal surveys; at pre-intervention baseline and 3- and 6-month follow-up post-enrollment. Patient-level correlates of 5As receipt at baseline, 3 months, and 6 months were identified using multilevel regression models. Results: At baseline, patient-reported rates of 5As receipt from oncology clinicians ranged from 85.17% (Ask) to 32.24% (Arrange). Delivery declined from baseline to 6-month follow-up for all 5As, with the largest declines observed for Ask, Advise, Assess, and Assist-Counseling. Diagnosis of a smoking-related cancer was associated with greater odds of 5As receipt at baseline but lower odds at 6-month follow-up. At each time point, female gender, religiosity, advanced disease, cancer-related stigma, and smoking abstinence were associated with lower odds of 5As receipt, while reporting a recent quit attempt prior to enrollment was associated with higher odds of 5As receipt. Conclusion: Oncology clinicians’ 5As delivery declined over time. Clinician delivery of the 5As varied based on patients’ sociodemographics, clinical and smoking characteristics, and psychosocial factors.
- Published
- 2023
10. The Prevalence and Perceived Utility of Mobile Health Technology Among Recently Incarcerated Homeless Adults
- Author
-
Audrey Montgomery, Jordan M. Neil, Michael B. Cannell, Jennifer Gonzalez, Ashley Cole, Chaelin K. Ra, Krista Kezbers, Jillian Robison, Darla E. Kendzor, and Michael S. Businelle
- Subjects
General Medicine - Published
- 2023
11. Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
- Author
-
Elyse R Park, Jordan M Neil, Elise Noonan, Sydney E Howard, Irina Gonzalez, Caylin Marotta, Amy J Wint, Douglas E Levy, Yuchiao Chang, Nancy A Rigotti, and Jennifer S Haas
- Subjects
Tobacco Use Cessation ,Cancer Research ,Lung Neoplasms ,Oncology ,Tobacco ,Humans ,Smoking Cessation ,Early Detection of Cancer - Abstract
The US Preventive Services Task Force recommends lung cancer screening (LCS) to promote early lung cancer detection, and tobacco cessation services are strongly recommended in adjunct. Screen ASSIST (NCT03611881) is a randomized factorial trial to ascertain the best tobacco treatment intervention for smokers undergoing LCS; trial outreach is conducted during 3 recruitment points (RPs): when LCS is ordered (RP1), at screening (RP2), and following results (RP3). Among 177 enrollees enrolled from April 2019 to March 2020, 31.6% enrolled at RP1, 13.0% at RP2, and 55.4% at RP3. The average number of enrollees (per 1000 recruitment days) was 2.26 in RP1, 3.37 in RP2, and 1.04 in RP3. LCS provides an opportunity to offer tobacco treatment at multiple clinical timepoints. Repeated and proactive outreach throughout the LCS experience was beneficial to enrolling patients in tobacco cessation services.
- Published
- 2022
12. A multi-method evaluation of tobacco treatment trial recruitment messages for current smokers recently diagnosed with cancer: A pilot factorial randomized control trial (Preprint)
- Author
-
Jordan M. Neil, Christian Senecal, Lauren Ballini, Yuchiao Chang, Brett Goshe, Elyse R. Park, Efren Flores, and Jamie S. Ostroff
- Abstract
BACKGROUND A cancer diagnosis can catalyze motivation to quit smoking. Tobacco treatment trials (TTTs) offer evidence-based cessation resources but suffer from low accrual rates. Digital outreach through clinician-delivered videos may improve recruitment efforts. However, understanding of how best to frame trial information and promote participation among smokers with a recent diagnosis is limited. OBJECTIVE This study aimed to identify which message frames were most effective at promoting intent to talk to a doctor about participating in a TTT for smokers recently diagnosed with cancer. METHODS From February-April 2019, current smokers diagnosed within the past 24 months were recruited from a national online panel company to a multi-method pilot randomized trial (N=99). Participants were randomly assigned to 1 of 9 videos in a 2 x 3 plus control factorial design that tested 3 unique message frame: (1) proximal vs. distal threats of smoking, (2) costs of continued smoking vs. benefits of quitting, and (3) gains of participating vs. loss of not participating in a TTT. The primary outcome was self-assessed intent to talk to a doctor about participating in a TTT. Phase 1: Analysis of variance examined the main effect within each message factor level and compared to control condition. Other message evaluation and effectiveness measures were also collected. A multivariable model explored sociodemographic, smoking and cancer characteristics, and message measures associated with intent to talk to a doctor. Phase 2: Open-text evaluations of the messages were analyzed using natural language processing software (Leximancer) to generate a thematic concept map and Linguistic Inquiry Word Count to identify and compare prevalence of linguistic markers between message factors. RESULTS A total of 76 participants completed the intervention. Participants who received the cost of continued smoking message frame were significantly more likely to intend to talk to their doctor about participating in a TTT than those who received the benefits of quitting frame (Mcosts=5.13 vs. Mbenefits=4.23, P=.038). Participants who received the proximal risks of continued smoking message frame were significantly more likely to seek more information about participating (MDistal=4.83 vs. MProximal=5.55, P=.04), and those who received the losses of not participating frame reported significantly improved perceptions about smoking cessation research (MGain=3.98 vs. MLoss=4.38, P=.013). Male participants (P=.006) and those with greater message relevancy (P=.001) were significantly more likely to intend to talk to their doctor. Participants’ perceptions about their smoking habits, as well as their motivation and readiness to quit smoking, were the most prevalent themes in the open-text data. Differences across message frames in the percentage of affective words were identified. CONCLUSIONS Multi-method approaches are needed to develop evidence-based recruitment messages for patients recently diagnosed with cancer. Future TTTs should evaluate the effectiveness of different message frames on smoker enrollment rates. CLINICALTRIAL
- Published
- 2022
13. Telehealth and racial disparities in colorectal cancer screening: A pilot study of how virtual clinician characteristics influence screening intentions
- Author
-
Eric J. Cooks, Kyle A. Duke, Jordan M. Neil, Melissa J. Vilaro, Danyell Wilson-Howard, Francois Modave, Thomas J. George, Folakemi T. Odedina, Benjamin C. Lok, Peter Carek, Eric B. Laber, Marie Davidian, and Janice L. Krieger
- Subjects
General Medicine - Abstract
Introduction: Racial disparities in colorectal cancer (CRC) can be addressed through increased adherence to screening guidelines. In real-life encounters, patients may be more willing to follow screening recommendations delivered by a race concordant clinician. The growth of telehealth to deliver care provides an opportunity to explore whether these effects translate to a virtual setting. The primary purpose of this pilot study is to explore the relationships between virtual clinician (VC) characteristics and CRC screening intentions after engagement with a telehealth intervention leveraging technology to deliver tailored CRC prevention messaging. Methods: Using a posttest-only design with three factors (VC race-matching, VC gender, intervention type), participants (N = 2267) were randomised to one of eight intervention treatments. Participants self-reported perceptions and behavioral intentions. Results: The benefits of matching participants with a racially similar VC trended positive but did not reach statistical significance. Specifically, race-matching positively influenced screening intentions for Black participants but not for Whites (b = 0.29, p = 0.10). Importantly, perceptions of credibility, attractiveness, and message relevance significantly influenced screening intentions and the relationship with race-matching. Conclusions: To reduce racial CRC screening disparities, investments are needed to identify patient-focused interventions to address structural barriers to screening. This study suggests that telehealth interventions that match Black patients with a Black VC can enhance perceptions of credibility and message relevance, which may then improve screening intentions. Future research is needed to examine how to increase VC credibility and attractiveness, as well as message relevance without race-matching.
- Published
- 2022
14. Development of a Credible Virtual Clinician Promoting Colorectal Cancer Screening via Telehealth Apps for and by Black Men: Qualitative Study
- Author
-
Taylor T Ashley, Lauren N. Griffin, Thomas J. George, Jordan M. Neil, Melissa J. Vilaro, Benjamin Lok, Peter J. Carek, Danyell Wilson-Howard, François Modave, Mohan Zalake, Fatemeh Tavassoli, Eric Cooks, Janice L. Krieger, and Folakemi G Odedina
- Subjects
telehealth ,Population ,Applied psychology ,digital health ,Psychological intervention ,Medicine (miscellaneous) ,colorectal cancer ,Health Informatics ,Telehealth ,virtual human ,prevention ,Credibility ,cancer ,Black men ,education ,app ,development ,Original Paper ,education.field_of_study ,Source credibility ,Focus group ,Health equity ,Computer Science Applications ,cancer screening ,technology ,eHealth ,Psychology ,Qualitative research - Abstract
Background Traditionally, promotion of colorectal cancer (CRC) screening among Black men was delivered by community health workers, patient navigators, and decision aids (printed text or video media) at clinics and in the community setting. A novel approach to increase CRC screening of Black men includes developing and utilizing a patient-centered, tailored message delivered via virtual human technology in the privacy of one’s home. Objective The objective of this study was to incorporate the perceptions of Black men in the development of a virtual clinician (VC) designed to deliver precision messages promoting the fecal immunochemical test (FIT) kit for CRC screening among Black men in a future clinical trial. Methods Focus groups of Black men were recruited to understand their perceptions of a Black male VC. Specifically, these men identified source characteristics that would enhance the credibility of the VC. The modality, agency, interactivity, and navigability (MAIN) model, which examines how interface features affect the user’s psychology through four affordances (modality, agency, interactivity, and navigability), was used to assess the presumed credibility of the VC and likability of the app from the focus group transcripts. Each affordance triggers heuristic cues that stimulate a positive or a negative perception of trustworthiness, believability, and understandability, thereby increasing source credibility. Results In total, 25 Black men were recruited from the community and contributed to the development of 3 iterations of a Black male VC over an 18-month time span. Feedback from the men enhanced the visual appearance of the VC, including its movement, clothing, facial expressions, and environmental surroundings. Heuristics, including social presence, novelty, and authority, were all recognized by the final version of the VC, and creditably was established. The VC was named Agent Leveraging Empathy for eXams (ALEX) and referred to as “brother-doctor,” and participants stated “wanting to interact with ALEX over their regular doctor.” Conclusions Involving Black men in the development of a digital health care intervention is critical. This population is burdened by cancer health disparities, and incorporating their perceptions in telehealth interventions will create awareness of the need to develop targeted messages for Black men.
- Published
- 2021
15. CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in Oklahoma
- Author
-
Amanda E. Janitz, Jordan M. Neil, Laura A. Bray, Lori L. Jervis, Laura Ross, Janis E. Campbell, Mark P. Doescher, Paul G. Spicer, Mary L. Williams, April K. Lopez, Conce A. Uribe-Frias, Sixia Chen, Judith A. James, and Timothy M. VanWagoner
- Subjects
Multiphase optimization strategy ,COVID-19 ,Vaccine hesitancy ,Underserved communities ,Rural health disparities ,Community-engaged intervention ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Oklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Methods Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Discussion Because of Oklahoma’s higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. Trial Registration ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.